-
ALSO READ
More Than 88.5 Lakh Covid-19 Vaccine Doses Administered In India
Cadila Health seeks nod to start phase III clinical trials of ZyCoV-D
Panacea Biotec soars on successful dengue vaccine trial
We Will Have To Work In A PPP Model To Ensure Vaccination Against COVID For 1.3 Billion People: Piyush Goyal
AstraZeneca Pharma drops after UK parent pauses COVID-19 vaccine trial
-
India is the third topmost country globally with the highest cumulative vaccination numbers, after USA and the UK. As on 18thFebruary, 2021, till 8:00 AM, the cumulative vaccination coverage to healthcare workers (HCWs) and frontline workers (FLWs) against COVID19 in the country has crossed 94 lakhs. 94,22,228 vaccine doses have been given to beneficiaries through 1,99,305 sessions, as per the provisional report till 8 am today. These include 61,96,641 HCWs (1st dose), 3,69,167 HCWs (2nd dose) and 28,56,420 FLWs (1st dose).
The 2nd dose of COVID19 vaccination started on 13th February, 2021 for those beneficiaries who have completed 28 days after receipt of the 1st dose. The vaccination of the FLWs started from 2nd Feb 2021. As on Day-33 of the vaccination drive (18th February, 2021), total 4,22,998 vaccine doses were given across 7,932 sessions. Out of which, 3,30,208 beneficiaries were vaccinated for 1st dose and 92,790 received the 2nd dose of vaccine. 58.20% of those who have received the second dose are concentrated in 7 States. Karnataka alone accounts for 14.74% (54,397 doses).
Moving ahead on the COVID19 trajectory, India's cumulative recoveries show a progressive increment on a daily basis. It stands at 1.06 Cr (1,06,56,845) today. The Recovery Rate is 97.32%. Rising recoveries along with contained daily deaths have ensured a sustained fall in the Active Caseload. India's present Active Cases (1,37,342) constitute just 1.25% of the total positive cases. 11,987 patients have recovered and discharged in the last 24 hours.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU